Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Capital Expenditures of $23000.0 for Q1 2026, down 14.81% year-over-year from $27000.0 in Q1 2025, and down 87.29% quarter-over-quarter from $181000.0 in Q3 2025.
Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Capital Expenditures for 10 consecutive years, with $23000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 14.81% year-over-year to $23000.0; the TTM figure through Mar 2026 stood at $204000.0 (down 1.45% YoY), while the FY2025 annual figure was $208000.0, up 33.33% from the prior year.
- Capital Expenditures eased to $23000.0 in Q1 2026 per TECX's latest filing, from $181000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $267000.0 in Q4 2022 and bottomed at -$215000.0 in Q3 2023.
- Historically, Capital Expenditures has averaged $43933.3 across 5 years, with a median of $24000.0 in 2024.
- Annual changes were most pronounced in 2023 — Capital Expenditures soared 421.95% — and 2024, when it slumped 400.0%.
- Tectonic Therapeutic's Capital Expenditures stood at $267000.0 in 2022, then tumbled by 100.75% to -$2000.0 in 2023, then jumped by 250.0% to $3000.0 in 2024, then soared by 5933.33% to $181000.0 in 2025, then plunged by 87.29% to $23000.0 in 2026.
- Business Quant data shows TECX's Capital Expenditures at $23000.0 in Q1 2026, $181000.0 in Q3 2025, and $27000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 75,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75,000.00 |
| Jun 30, 2026 | 75,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 153,000.00 |
| Sep 30, 2024 | 153,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -215,000.00 |
| Sep 30, 2023 | -215,000.00 |